» Articles » PMID: 21292721

Enterovirus Infection and Type 1 Diabetes Mellitus: Systematic Review and Meta-analysis of Observational Molecular Studies

Overview
Journal BMJ
Specialty General Medicine
Date 2011 Feb 5
PMID 21292721
Citations 221
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To review the association between current enterovirus infection diagnosed with molecular testing and development of autoimmunity or type 1 diabetes.

Design: Systematic review and meta-analysis of observational studies, analysed with random effects models.

Data Sources: PubMed (until May 2010) and Embase (until May 2010), no language restrictions, studies in humans only; reference lists of identified articles; and contact with authors. Study eligibility criteria Cohort or case-control studies measuring enterovirus RNA or viral protein in blood, stool, or tissue of patients with pre-diabetes and diabetes, with adequate data to calculate an odds ratio and 95% confidence intervals.

Results: The 24 papers and two abstracts (all case-control studies) that met the eligibility criteria included 4448 participants. Study design varied greatly, with a high level of statistical heterogeneity. The two separate outcomes were diabetes related autoimmunity or type 1 diabetes. Meta-analysis showed a significant association between enterovirus infection and type 1 diabetes related autoimmunity (odds ratio 3.7, 95% confidence interval 2.1 to 6.8; heterogeneity χ(2)/df = 1.3) and clinical type 1 diabetes (9.8, 5.5 to 17.4; χ(2)/df = 3.2).

Conclusions: There is a clinically significant association between enterovirus infection, detected with molecular methods, and autoimmunity/type 1 diabetes. Larger prospective studies would be needed to establish a clear temporal relation between enterovirus infection and the development of autoimmunity and type 1 diabetes.

Citing Articles

Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.

Galipeau Y, Cooper C, Langlois M Front Immunol. 2025; 15():1509289.

PMID: 39835117 PMC: 11743527. DOI: 10.3389/fimmu.2024.1509289.


Role of Protein Tyrosine Phosphatases in Inflammatory Bowel Disease, Celiac Disease and Diabetes: Focus on the Intestinal Mucosa.

Bellomo C, Furone F, Rotondo R, Ciscognetti I, Carpinelli M, Nicoletti M Cells. 2024; 13(23).

PMID: 39682729 PMC: 11640621. DOI: 10.3390/cells13231981.


Research progress and application prospects of animal models of group B Coxsackievirus infections.

Weng S, Zhu R, Wu Y, Xia N, Xu L, Cheng T Emerg Microbes Infect. 2024; 14(1):2441391.

PMID: 39665300 PMC: 11703136. DOI: 10.1080/22221751.2024.2441391.


Antigen-specific T cell responses in autoimmune diabetes.

Dwyer A, Shaheen Z, Fife B Front Immunol. 2024; 15:1440045.

PMID: 39211046 PMC: 11358097. DOI: 10.3389/fimmu.2024.1440045.


Type 1 Diabetes in a Pediatric Patient With Beckwith-Wiedemann Syndrome.

Ehsan L, Anz R, Asebes H, Nickson N, Ergun-Longmire B JCEM Case Rep. 2024; 2(7):luae122.

PMID: 39027637 PMC: 11255477. DOI: 10.1210/jcemcr/luae122.


References
1.
Ylipaasto P, Klingel K, Lindberg A, Otonkoski T, Kandolf R, Hovi T . Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004; 47(2):225-39. DOI: 10.1007/s00125-003-1297-z. View

2.
Jacques J, Moret H, Minette D, Leveque N, Jovenin N, Deslee G . Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005. J Clin Microbiol. 2007; 46(1):206-13. PMC: 2224256. DOI: 10.1128/JCM.01414-07. View

3.
Hadden D, Connolly J, Montgomery D, Weaver J . Coxsackie B virus diabetes. Br Med J. 1972; 4(5842):729. PMC: 1786906. DOI: 10.1136/bmj.4.5842.729-a. View

4.
Wagenknecht L, Roseman J, Herman W . Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackievirus B5. Am J Epidemiol. 1991; 133(10):1024-31. DOI: 10.1093/oxfordjournals.aje.a115811. View

5.
Kawashima H, Ihara T, Ioi H, Oana S, Sato S, Kato N . Enterovirus-related type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan. J Infect. 2004; 49(2):147-51. DOI: 10.1016/j.jinf.2004.01.012. View